• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Accenture plc

    5/30/25 6:53:18 AM ET
    $ACN
    Business Services
    Consumer Discretionary
    Get the next $ACN alert in real time by email
    SD 1 acn2025formsd.htm SD Document

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM SD
    Specialized Disclosure Report
    image_0a.jpg
    Accenture plc
    (Exact name of the Registrant as specified in its charter)

    Ireland001-3444898-0627530
    (State or other jurisdiction
    of incorporation or organization)
    (Commission
    File Number)
    (I.R.S. Employer Identification No.)


    1 Grand Canal Square,
    Grand Canal Harbour,
    Dublin 2, Ireland
    (Address of principal executive offices) (Zip Code)

    Joel Unruch
    General Counsel & Corporate Secretary
    (312) 693-5009
    (Name and telephone number, including area code, of the person to contact in connection with this report.)


    Check the appropriate box to indicate the rule pursuant to which this Form is being submitted, and provide the period to which the information in this Form applies:

    ☒Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024

    ☐Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended _________.





    Section 1 – Conflict Minerals Disclosure
    Item 1.01 Conflict Minerals Disclosure and Report
    A copy of Accenture plc’s Conflict Minerals Report for the reporting period January 1, 2024 to December 31, 2024 is provided as Exhibit 1.01 hereto and is being posted to the publicly available internet site https://investor.accenture.com/filings-and-reports/sec-filings upon the filing of this Form SD.

    Item 1.02 Exhibit
    The Conflict Minerals Report described in Item 1.01 is filed as Exhibit 1.01 to this Form SD.

    Section 3 – Exhibits
    Item 3.01 Exhibits
    Exhibit 1.01 – Conflict Minerals Report for the reporting period January 1, 2024 to December 31, 2024.





    Signatures
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
     
    Date: May 30, 2025ACCENTURE PLC
    By: /s/ Joel Unruch   
    Name: Joel Unruch
    Title: General Counsel & Corporate Secretary




    Get the next $ACN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ACN

    DatePrice TargetRatingAnalyst
    3/17/2025$390.00Neutral → Outperform
    Robert W. Baird
    1/8/2025$425.00Peer Perform → Outperform
    Wolfe Research
    12/6/2024$370.00 → $420.00Neutral → Buy
    Goldman
    10/30/2024$375.00Outperform → Neutral
    Exane BNP Paribas
    9/30/2024$321.00 → $400.00Hold → Buy
    TD Cowen
    9/26/2024$329.00 → $395.00Neutral → Overweight
    Piper Sandler
    7/19/2024$400.00Neutral → Buy
    UBS
    6/26/2024$382.00 → $300.00Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings